You are here: Industry Insights > vaccine

News List

Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation americanpharmaceuticalreview
January 30, 2018
Takeda Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.
Mother’s antibodies may worsen dengue infection in children biospectrumasia
January 29, 2018
A dengue vaccine that stimulates a strong T cell response in babies has been found to provide better and broader protection than vaccines which induce the production of mainly antibodies.
New vaccine provides universal protection against influenza A, study finds pharmafile
January 25, 2018
Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to provide long-lasting immunity in mice.
Study Shows Superiority of PharmaJet Needle-Free Injector for Poliovirus Vaccine Administration biospace
January 24, 2018
PharmaJet, the maker of innovative, needle-free injection technology, announced that a study was published in Heliyon Journal showing PharmaJet needle-free injection is superior to needle and syringe for fractional dose poliovirus vaccine campaigns.(1)
Fooya! founder in patent war over digital vaccine with US Pharma giant economictimes.indiatimes
December 27, 2017
Fooya! founder and inventor of 'digital vaccine' technology Bhargav Sri Prakash has run into a trademark war with USD 5-billion pharma giant Moderna Therapeutics.
Bangladesh moves to protect Rohingya children from diphtheria biospectrumasia
December 15, 2017
Accelerated immunization will cover nearly 255 000 children in Ukhiya and Teknaf sub-districts in Cox’s Bazar, while the Government and health partners continue to increase support for diphtheria treatment and prevention
Single, high-dose vaccine could provide better protection against cholera outbreaks, new research sh pharmafile
December 13, 2017
A team at UMSOM has been evaluating the efficacy of a single high-dose live vaccine in the treatment of cholera rather than the traditional two-dose inactivated vaccine approach, hoping to more successfully protect the recent massive outbreak.
Gene-based Zika vaccine is safe and induces immune response in healthy adults worldpharmanews
December 07, 2017
Results from two Phase I clinical trials show that experimental Zika vaccines developed by government scientists at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health are safe and induce immune responses in heal
Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease europeanpharmaceuticalreview
November 27, 2017
Researchers have discovered that a virus-like particle vaccine can prime the body’s immune response and prevent the severe respiratory diseases…
Merck will delay filing Ebola vaccine for approval until 2018, company confirms fiercepharma
November 22, 2017
Despite a frantic effort to rush Ebola vaccines through testing during a deadly epidemic, Merck & Co. will fall short of its goal to file its candidate for FDA approval this year, the company confirmed Tuesday.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page